The Cancer Prevention and Research Institute of Texas (CPRIT) is one of the largest state-funded cancer research funding organizations in the country, with over $6 billion authorized since its creation. For Texas biotech startups developing cancer-related therapeutics, diagnostics, devices, or technologies, CPRIT's Product Development Research Awards represent a significant funding opportunity that does not require giving up equity.
CPRIT Product Development Awards
CPRIT's product development program funds Texas-based companies commercializing cancer-related products. Awards can range from several hundred thousand dollars to tens of millions of dollars, depending on the stage of development and scope of the project.
- Eligible companies: For-profit companies headquartered in Texas or willing to relocate principal operations to Texas. The company must be developing a product with a cancer application.
- Eligible products: Therapeutics (drugs, biologics, cell therapies), diagnostics (molecular, imaging), medical devices, drug delivery systems, and enabling technologies for cancer prevention, detection, or treatment.
- Award structure: CPRIT provides funding as a contract, not a grant in the traditional sense. The state receives certain revenue-sharing rights and milestone-based deliverables are required.
- Matching requirement: Companies must demonstrate matching funds (typically 1:1 for later-stage awards, with flexibility for earlier-stage companies).
Why CPRIT Is Valuable for Biotech Startups
- Non-dilutive funding: Unlike venture capital, CPRIT awards do not require giving up equity. This preserves ownership for founders and existing investors.
- Significant award sizes: CPRIT awards are larger than most SBIR grants, allowing companies to fund clinical trials, manufacturing scale-up, and regulatory activities.
- Validation signal: A CPRIT award is a strong signal to venture investors, strategic partners, and acquirers that the company has passed rigorous external scientific review.
- Texas ecosystem integration: CPRIT connects funded companies with the Texas Medical Center, MD Anderson, UT Southwestern, and other institutional resources.
Application Process
- Monitor CPRIT's website for open Request for Applications (RFAs) in the product development category
- Submit a letter of intent during the open period
- If invited, submit a full application including scientific rationale, development plan, team qualifications, budget, and business plan
- Applications undergo scientific and business peer review
- CPRIT's Oversight Committee makes final funding decisions
Complementary Programs
- SBIR/STTR: Federal grants up to $2 million for early-stage biotech R&D. NIH is the primary agency for biotech. SBIR/NIH guide.
- R&D tax credits: Biotech R&D expenses qualify for federal R&D tax credits, including the payroll tax offset for startups under $5 million in revenue. R&D credits guide.
- Texas Enterprise Fund: For biotech companies creating significant jobs in Texas. TEF guide.
- Orphan drug designation: FDA designations for rare cancer indications provide additional tax credits and market exclusivity
Bottom Line
CPRIT is a uniquely valuable resource for Texas biotech startups working on cancer-related products. The combination of large, non-dilutive awards, rigorous scientific validation, and integration with the Texas biotech ecosystem makes it one of the strongest state-level funding programs for life sciences companies in the country. Companies must be willing to base operations in Texas and meet milestone-driven deliverables.
Not sure which programs may fit your biotech startup? Our free screening report checks your business against 150+ verified programs — grants, tax credits, loans, and incentives — and shows you which ones may match. Start your free screening →